Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061337) titled 'A study to evaluate rapid on-site evaluation (ROSE) for pancreatic duct cytology in pancreatic duct narrowing' on April 21.
Study Type:
Observational
Primary Sponsor:
Institute - Other
Condition:
Condition - Pancreatic duct stricture
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the diagnostic performance and sample adequacy of pancreatic duct brushing cytology with rapid on-site evaluation (ROSE) for pancreatic duct stricture.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
=18 years
Written informed consent obtained
Key exclusion criteria - Performance status >= 3
Anatomical difficulty for the procedure
Pregnant patients
Patients deemed inappropriate by the investigator
Target Size - 25
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 11 Month 14 Day
Anticipated trial start date - 2026 Year 04 Month 21 Day
Last follow-up date - 2028 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070184
Disclaimer: Curated by HT Syndication.
